Effect of Hand Message on Catheter Insertion

November 26, 2025 updated by: Handan Eren, University of Yalova

The Effect of Arm Message on the Success of Peripheral Intravenous Catheter Insertion in Breast Cancer Patients Undergoing Chemotherapy

This is a randomized controlled study to investigate the effect of arm message on the success of peripheral intravenous catheter insertion in breast cancer patients undergoing chemotherapy. There are two groups in our study (control group=30, experimental group=30). The investigator applied hand massage to patients in experimental group before peripheral intravenous catheter insertion. The investigators evaluated the succesfull peripheral catheter insertion time, anxiety level, and satisfaction level of the patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Introduction: Peripheral intravenous catheter (PIVK) placement becomes difficult in patients diagnosed with breast cancer who receive chemotherapy because vein visibility decreases.

Objective: The aim of this study is to determine the effect of arm massage applied to patients diagnosed with breast cancer receiving chemotherapy on the success of peripheral intravenous catheter placement.

Method: The study will conducted in a randomized controlled experimental type in an outpatient chemotherapy unit of a hospital.The sample of the study will consist of 60 patients who met the inclusion criteria (experimental group = 30, control group = 30). Patients in the experimental group will receive arm massage before peripheral intravenous catheter placement, while patients in the control group will receive no intervention. The time to successful catheter placement, patient anxiety, and satisfaction levels regarding the procedure will be recorded.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • diagnosed as breast cancer,
  • having had the first course of chemotherapy,
  • patients who has 1,2 and 3 vein degree

Exclusion Criteria:

  • More than 2 unsuccessful attempts at PICK placement,
  • The individual wants to leave the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
hand massage
Other: Hand massage
Classical hand massage that inclued effleurage, and petrisage.
No Intervention: control group
no intervention has applied

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the success of peripheral intravenous catheter insertion
Time Frame: assessed up to 6 months
Time until successful catheter placement
assessed up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient satisfaction level scale
Time Frame: assessed up to 6 months
Patient satisfaction levels with peripheral intravenous catheter placement procedure
assessed up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Yalova

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2024

Primary Completion (Actual)

February 1, 2025

Study Completion (Actual)

February 1, 2025

Study Registration Dates

First Submitted

July 7, 2025

First Submitted That Met QC Criteria

November 26, 2025

First Posted (Estimated)

December 9, 2025

Study Record Updates

Last Update Posted (Estimated)

December 9, 2025

Last Update Submitted That Met QC Criteria

November 26, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 224/187

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe